Alcon Inc. Share Price

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 16:30:41 31/05/2024 BST 5-day change 1st Jan Change
80.34 CHF +0.17% Intraday chart for Alcon Inc. -2.92% +22.39%

Financials

Sales 2024 * 9.99B 9.01B 783B Sales 2025 * 10.66B 9.62B 836B Capitalization 43.87B 39.56B 3,440B
Net income 2024 * 937M 845M 73.47B Net income 2025 * 1.21B 1.09B 94.64B EV / Sales 2024 * 4.69 x
Net Debt 2024 * 3B 2.71B 235B Net Debt 2025 * 1.73B 1.56B 135B EV / Sales 2025 * 4.28 x
P/E ratio 2024 *
48.2 x
P/E ratio 2025 *
38.9 x
Employees 25,000
Yield 2024 *
0.32%
Yield 2025 *
0.38%
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.80%
1 week-1.78%
Current month+13.31%
1 month+13.15%
3 months+5.97%
6 months+22.58%
Current year+22.73%
More quotes
1 week
79.44
Extreme 79.44
82.58
1 month
70.98
Extreme 70.98
83.34
Current year
62.24
Extreme 62.24
83.34
1 year
61.28
Extreme 61.28
83.34
3 years
55.22
Extreme 55.22
83.34
5 years
38.63
Extreme 38.625
83.34
10 years
38.63
Extreme 38.625
83.34
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 30/06/16
Director of Finance/CFO 56 07/04/19
Chief Tech/Sci/R&D Officer - 31/05/11
Members of the board TitleAgeSince
Chairman 68 30/06/18
Director/Board Member 65 31/12/18
Director/Board Member 60 31/01/19
More insiders
Date Price Change Volume
31/05/24 80.34 +0.17% 6 341 227
30/05/24 80.2 +0.25% 759,990
29/05/24 80 -1.06% 977,244
28/05/24 80.86 -1.73% 904,000
27/05/24 82.28 +0.32% 289,879

Delayed Quote Swiss Exchange, May 31, 2024 at 03:34 pm

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
88.74 USD
Average target price
93.37 USD
Spread / Average Target
+5.22%
Consensus